MedTrace Logo

Gastrointestinal Tolerance Assessment of T2309

NCT04596605 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2021-07-28

No results posted yet for this study

Summary

Gastrointestinal Tolerance assessment of T2309 compared to a food supplement in 50 subjects.

Conditions

  • Healthy Adult Subjects

Interventions

OTHER

T2309

Food for Special Medical Purpose / 4 capsules daily for 12 weeks

DIETARY_SUPPLEMENT

Nutrof Total

2 capsules daily for 12 weeks

Sponsors & Collaborators

  • Laboratoires Thea

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-15
Primary Completion
2021-03-04
Completion
2021-03-04

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04596605 on ClinicalTrials.gov